172 related articles for article (PubMed ID: 37310570)
1. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists.
Wada T; Shimizu S; Koizumi M; Sofue T; Nishiwaki H; Sasaki S; Nakaya I; Oe Y; Ishimoto T; Furuichi K; Okada H; Kurita N
Clin Exp Nephrol; 2023 Sep; 27(9):767-775. PubMed ID: 37310570
[TBL] [Abstract][Full Text] [Related]
2. Variations in actual practice patterns and their deviations from the clinical practice guidelines for nephrotic syndrome in Japan: certified nephrologists' questionnaire survey.
Niihata K; Nishiwaki H; Kurita N; Okada H; Maruyama S; Narita I; Shibagaki Y; Nakaya I
Clin Exp Nephrol; 2019 Nov; 23(11):1288-1297. PubMed ID: 31385161
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
4. Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020.
Sasaki S; Shimizu S; Nakaya I; Miyaoka Y; Koizumi M; Nishiwaki H; Sofue T; Ishimoto T; Kurita N; Wada T
Clin Exp Nephrol; 2024 Jun; 28(6):531-538. PubMed ID: 38402500
[TBL] [Abstract][Full Text] [Related]
5. Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists.
Koizumi M; Ishimoto T; Shimizu S; Sasaki S; Kurita N; Wada T
PLoS One; 2024; 19(3):e0299053. PubMed ID: 38551948
[TBL] [Abstract][Full Text] [Related]
6. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[TBL] [Abstract][Full Text] [Related]
7. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Fukami K; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Yoshio T; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2018 Dec; 22(6):1266-1280. PubMed ID: 29679356
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic management of adult idiopathic nephrotic syndrome.
Alaniz C; Brosius FC; Palmieri J
Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
[TBL] [Abstract][Full Text] [Related]
9. Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists.
Miyaoka Y; Kurita N; Sofue T; Nishiwaki H; Koizumi M; Shimizu S; Sasaki S; Ishimoto T; Wada T
Clin Exp Nephrol; 2024 Mar; 28(3):217-224. PubMed ID: 37924431
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the nephrotic syndrome with cyclosporin A.
Ponticelli C
J Autoimmun; 1992 Apr; 5 Suppl A():315-24. PubMed ID: 1503627
[TBL] [Abstract][Full Text] [Related]
11. The increasing incidence of initial steroid resistance in childhood nephrotic syndrome.
Banaszak B; Banaszak P
Pediatr Nephrol; 2012 Jun; 27(6):927-32. PubMed ID: 22231438
[TBL] [Abstract][Full Text] [Related]
12. Nephrotic Syndrome After Hematopoietic Stem Cell Transplant: Outcomes in Iran.
Saddadi F; Alidadi A; Hakemi M; Bahar B
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):90-92. PubMed ID: 28260442
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
Heering P; Schneider A; Grabensee B; Plum J
Dtsch Med Wochenschr; 2001 Oct; 126(40):1093-8. PubMed ID: 11588659
[TBL] [Abstract][Full Text] [Related]
14. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].
Zietse R; Weimar W
Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1749-53. PubMed ID: 1407123
[No Abstract] [Full Text] [Related]
15. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
Kurasawa S; Kato S; Ozeki T; Akiyama S; Ishimoto T; Mizuno M; Tsuboi N; Kato N; Kosugi T; Maruyama S;
Clin Exp Nephrol; 2024 May; 28(5):431-439. PubMed ID: 38267800
[TBL] [Abstract][Full Text] [Related]
16. Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
Parikh RV; Tan TC; Fan D; Law D; Salyer AS; Yankulin L; Wojcicki JM; Zheng S; Ordonez JD; Chertow GM; Khoshniat-Rad F; Yang J; Go AS
PLoS One; 2021; 16(10):e0257674. PubMed ID: 34648518
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the treatment of adult nephrotic syndrome].
Yokoyama H; Asaka M; Yamaya H; Wada T
Nihon Jinzo Gakkai Shi; 2007; 49(2):108-12. PubMed ID: 17375618
[No Abstract] [Full Text] [Related]
18. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
19. Substantial practice variation exists in the management of childhood nephrotic syndrome.
Samuel S; Morgan CJ; Bitzan M; Mammen C; Dart AB; Manns BJ; Alexander RT; Erickson RL; Grisaru S; Wade AW; Blydt-Hansen T; Feber J; Arora S; Licht C; Zappitelli M
Pediatr Nephrol; 2013 Dec; 28(12):2289-98. PubMed ID: 23917450
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of primary nephrotic syndrome in Egyptian children.
Kaddah A; Sabry S; Emil E; El-Refaey M
J Nephrol; 2012; 25(5):732-7. PubMed ID: 22101675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
